Actively Recruiting
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Led by Brigham and Women's Hospital · Updated on 2025-09-16
400
Participants Needed
1
Research Sites
178 weeks
Total Duration
On this page
Sponsors
B
Brigham and Women's Hospital
Lead Sponsor
E
Esperion Therapeutics, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.
CONDITIONS
Official Title
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 18 years or older
- Seen in Cardiovascular Medicine Clinic, Primary Care, Podiatry, Vascular Surgery, or Diabetology
- Have a medical history, visit diagnosis, or problem list entry of peripheral artery disease (PAD)
- Not currently prescribed LDL-C lowering therapy
You will not qualify if you...
- Taking statins, ezetimibe, bempedoic acid, PCSK9 inhibitors, inclisiran, or combination therapies
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
G
Gregory Piazza
CONTACT
C
Candrika D Kharaini
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here